Axonal regeneration and sprouting as a potential therapeutic target for nervous system disorders

被引:30
作者
Marshall, Katherine L. [1 ]
Farah, Mohamed H. [1 ]
机构
[1] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD 21205 USA
关键词
amyotrophic lateral sclerosis; axonal regeneration; dying-back axonopathy; in vitro neuromuscular junction; iPSC-derived motor neurons; microfluidic device; motor axon sprouting; AMYOTROPHIC-LATERAL-SCLEROSIS; TERMINAL SCHWANN-CELLS; PLACEBO-CONTROLLED TRIAL; NEUROMUSCULAR-JUNCTION; SKELETAL-MUSCLE; MOTOR-NEURONS; SPINAL-CORD; MOUSE MODEL; MOLECULAR-MECHANISMS; HUNTINGTONS-DISEASE;
D O I
10.4103/1673-5374.308077
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Nervous system disorders are prevalent health issues that will only continue to increase in frequency as the population ages. Dying-back axonopathy is a hallmark of many neurologic diseases and leads to axonal disconnection from their targets, which in turn leads to functional impairment. During the course of many of neurologic diseases, axons can regenerate or sprout in an attempt to reconnect with the target and restore synapse function. In amyotrophic lateral sclerosis (ALS), distal motor axons retract from neuromuscular junctions early in the disease-course before significant motor neuron death. There is evidence of compensatory motor axon sprouting and reinnervation of neuromuscular junctions in ALS that is usually quickly overtaken by the disease course. Potential drugs that enhance compensatory sprouting and encourage reinnervation may slow symptom progression and retain muscle function for a longer period of time in ALS and in other diseases that exhibit dying-back axonopathy. There remain many outstanding questions as to the impact of distinct disease-causing mutations on axonal outgrowth and regeneration, especially in regards to motor neurons derived from patient induced pluripotent stem cells. Compartmentalized microfluidic chambers are powerful tools for studying the distal axons of human induced pluripotent stem cells-derived motor neurons, and have recently been used to demonstrate striking regeneration defects in human motor neurons harboring ALS disease-causing mutations. Modeling the human neuromuscular circuit with human induced pluripotent stem cells-derived motor neurons will be critical for developing drugs that enhance axonal regeneration, sprouting, and reinnervation of neuromuscular junctions. In this review we will discuss compensatory axonal sprouting as a potential therapeutic target for ALS, and the use of compartmentalized microfluidic devices to find drugs that enhance regeneration and axonal sprouting of motor axons.
引用
收藏
页码:1901 / 1910
页数:10
相关论文
共 175 条
  • [1] A post-hoc subgroup analysis of outcomes in the first phase III clinical study of edaravone (MCI-186) in amyotrophic lateral sclerosis
    Abe, Koji
    Itoyarna, Yasuto
    Tsuji, Shoji
    Sobue, Gen
    Aoki, Masashi
    Doyu, Manabu
    Hamada, Chikuma
    Togo, Masanori
    Yoneoka, Takatomo
    Tanaka, Masahiko
    Akimotot, Makoto
    Nakamura, Kazue
    Takahashi, Fumihiro
    Kondo, Kazuoki
    Yoshino, Hiide
    [J]. AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2017, 18 : 11 - 19
  • [2] Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS
    Allodi, Ilary
    Comley, Laura
    Nichterwitz, Susanne
    Nizzardo, Monica
    Simone, Chiara
    Benitez, Julio Aguila
    Cao, Ming
    Corti, Stefania
    Hedlund, Eva
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [3] Specificity of peripheral nerve regeneration: Interactions at the axon level
    Allodi, Ilary
    Udina, Esther
    Navarro, Xavier
    [J]. PROGRESS IN NEUROBIOLOGY, 2012, 98 (01) : 16 - 37
  • [4] Projected increase in amyotrophic lateral sclerosis from 2015 to 2040
    Arthur, Karissa C.
    Calvo, Andrea
    Price, T. Ryan
    Geiger, Joshua T.
    Chio, Adriano
    Traynor, Bryan J.
    [J]. NATURE COMMUNICATIONS, 2016, 7
  • [5] c-Jun Reprograms Schwann Cells of Injured Nerves to Generate a Repair Cell Essential for Regeneration
    Arthur-Farraj, Peter J.
    Latouche, Morwena
    Wilton, Daniel K.
    Quintes, Susanne
    Chabrol, Elodie
    Banerjee, Annbily
    Woodhoo, Ashwin
    Jenkins, Billy
    Rahman, Mary
    Turmaine, Mark
    Wicher, Grzegorz K.
    Mitter, Richard
    Greensmith, Linda
    Behrens, Axel
    Raivich, Gennadij
    Mirsky, Rhona
    Jessen, Kristjan R.
    [J]. NEURON, 2012, 75 (04) : 633 - 647
  • [6] A 3D culture model of innervated human skeletal muscle enables studies of the adult neuromuscular junction
    Bakooshli, Mohsen Afshar
    Lippmann, Ethan S.
    Mulcahy, Ben
    Iyer, Nisha
    Nguyen, Christine T.
    Tung, Kayee
    Stewart, Bryan A.
    van den Dorpel, Hubrecht
    Fuehrmann, Tobias
    Shoichet, Molly
    Bigot, Anne
    Pegoraro, Elena
    Ahn, Henry
    Ginsberg, Howard
    Zhen, Mei
    Ashton, Randolph Scott
    Gilbert, Penney M.
    [J]. ELIFE, 2019, 8
  • [7] Chondroitin sulphate proteoglycans: Key modulators of spinal cord and brain plasticity
    Bartus, K.
    James, N. D.
    Bosch, K. D.
    Bradbury, E. J.
    [J]. EXPERIMENTAL NEUROLOGY, 2012, 235 (01) : 5 - 17
  • [8] The influence of synaptic activity on neuronal health
    Bell, Karen F. S.
    Hardingham, Giles E.
    [J]. CURRENT OPINION IN NEUROBIOLOGY, 2011, 21 (02) : 299 - 305
  • [9] EXTENSIVE ELONGATION OF AXONS FROM RAT-BRAIN INTO PERIPHERAL-NERVE GRAFTS
    BENFEY, M
    AGUAYO, AJ
    [J]. NATURE, 1982, 296 (5853) : 150 - 152
  • [10] A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis
    Borasio, GD
    Robberecht, W
    Leigh, PN
    Emile, J
    Guiloff, RJ
    Jerusalem, F
    Silani, V
    Vos, PE
    Wokke, JHJ
    Dobbins, T
    [J]. NEUROLOGY, 1998, 51 (02) : 583 - 586